---
schema_version: "secwatch.filing_event.v1"
accession: "0001764013-23-000003"
form_type: "8-K"
ticker: "IMVT"
cik: "0001764013"
company_name: "Immunovant, Inc."
filed_at: "2023-01-09T23:59:59+00:00"
generated_at: "2026-06-20T18:04:10.953572+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Immunovant presents at J.P. Morgan Healthcare Conference with new corporate deck; no specific data disclosed

## Summary
- Presentation at 41st Annual J.P. Morgan Healthcare Conference beginning January 9, 2023.
- New corporate presentation provided to investors; no clinical or financial updates in filing.
- Filing does not contain specific new data or material changes to pipeline or guidance.

## SEC filing metadata
- accession: 0001764013-23-000003
- form_type: 8-K
- ticker: IMVT
- cik: 0001764013
- company_name: Immunovant, Inc.
- filed_at: 2023-01-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1764013/000176401323000003/0001764013-23-000003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1764013/000176401323000003/imvt-20230109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001764013-23-000003
- JSON: https://secwatch.observer/filing/0001764013-23-000003.json
- Plain text: https://secwatch.observer/filing/0001764013-23-000003.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.